bioecon Member area
Technology · Forestry & biomaterials / Wood & construction

Forest biopharma & phytochemicals

Forest- and plant-derived pharmaceutical compounds and phytochemicals — paclitaxel from Taxus, curcumin, aged-black-garlic and standardized botanical extracts — produced by Phyton Biotech, Indena, Sabinsa, Natural Remedies and Pharmactive.

Maturity 4/9 Risk: low Forestry US · EU · IN · CN Science: why it works → verified 2026-07-09 · 5 Sources (0 independent)

1 · What it gives

Forest biopharma & phytochemicals is the industry that turns forest and medicinal plants into pharmaceutical actives and standardized botanical ingredients. Phyton Biotech (Germany) produces paclitaxel by plant cell fermentation rather than yew-tree harvest, advancing sustainable taxane bioproduction; Indena (Italy, founded 1921) is a long-standing botanical-extract leader with a taxane-derivative process improving paclitaxel recovery from Taxus baccata; Sabinsa (USA) won Great-Britain Novel Food authorization for its Curcumin C3 Reduct® curcuminoid; Natural Remedies (India) runs an Animal Healthcare Innovation Center around Siddha-based herbal actives for veterinary use; and Pharmactive (Spain) supplies the clinically-studied ABG10+® aged-black-garlic and affron® saffron extracts. The route spans plant sourcing, solvent extraction, phytochemical standardization and clinical-grade evidence.

The key directions of forest biopharma & phytochemicals are:

  1. Taxane biosynthesis (Taxane Biosynthesis): paclitaxel and taxane API via plant cell fermentation and Taxus extraction (Phyton Biotech, Indena).
  2. Botanical solvent extraction (Botanical Solvent Extraction): standardized botanical active-ingredient extraction (Indena, Pharmactive).
  3. Phytochemical standardization (Phytochemical Standardization): marker-based standardization of curcuminoid/garlic/saffron actives (Sabinsa, Pharmactive).
  4. Plant cell fermentation (Plant Cell Fermentation): cultivation of plant cells in bioreactors to produce forest-plant actives without harvesting the tree (Phyton Biotech).

Sectoral value chain#

[forest / medicinal plant (Taxus, Curcuma, garlic, saffron)] ──> [biomass harvest / cell culture] ──> [extraction]
                                                                       │
                                                               (purification & standardization)
                                                                       │
                                                                       ▼
[drug / supplement ingredient] <─── [clinical evidence & formulation] <─────┘

Value chain levels#

LevelDescriptionKey inputs/outputs
Plant sourcingforest / medicinal plants or plant cell cultures as feedstockIn: plant biomass / cell line. Out: raw botanical.
Extractionsolvent extraction (or cell-fermentation harvest) of crude activesIn: raw botanical. Out: crude extract.
Purificationpurification to a standardized phytochemical activeIn: crude extract. Out: standardized active.
Standardizationmarker-based standardization to clinical-grade activesIn: standardized active. Out: API / ingredient.
Clinical evidenceclinical substantiation of the active’s effectIn: active. Out: evidence dossier.
Formulationformulation into drug or supplement dosage formsIn: API, dossier. Out: drug / supplement.

Cross-cutting technologies of the sector:

  • Plant cell fermentation (Plant Cell Fermentation): bioreactor plant-cell cultures producing forest-plant actives without tree harvest (Phyton Biotech paclitaxel).
  • Marker-based standardization (Marker-Based Standardization): quantifying marker compounds (curcuminoids, allicin, saffron crocins) for reproducible actives.
  • Taxane recovery (Taxane Recovery): improved Taxus paclitaxel recovery processes (Indena taxane-derivative patent).

2 · What it replaces 3 · matched by industry

D3E–Forest defoliator control (Siberian silk moth, spongy/gypsy moth, nun moth, pine moths) with Bt kurstaki, nucleopolyhedrovirus (NPV) and pheromone mating disruption — instead of aerial chemical insecticides
Replaces: Aerial spraying of pyrethroids (cypermethrin, deltamethrin), organophosphates, and chitin-synthesis inhibitors (diflubenzuron) over forests
PEST
D1E3Spruce bark beetle (Ips typographus) and pine beetle management by early sanitation felling, pheromone monitoring, anti-aggregation pheromones and forest diversification — instead of insecticide-treated trap logs, nets and log-pile spraying
Replaces: Pyrethroid (cypermethrin, alpha-cypermethrin)-treated trap logs, insecticide-netted log piles, spraying of timber stacks; historically …
PEST
D3E–Conifer root and butt rot (Heterobasidion) prevention by stump treatment with the competitive fungus Phlebiopsis gigantea (Rotstop) — instead of chemical stump treatments
Replaces: Urea and borate (disodium octaborate) stump treatments; historically other chemical stump treatments
PEST

3 · How to implement 6 steps

  1. 1
    Plant sourcingFermentation & cultivation
    Forest or medicinal plants (or plant cell cultures) supply the botanical feedstock; the output is raw botanical biomass or a cell-culture harvest.
    Who can do this step matched automatically
    Fermelanta Japan
    3,000 L pilot scale
    “We transform the traditional supply chain depending on agricultural cultivation and extraction into a next-gen microbial fermentation process that can offer low-cost and …”
    Spiber Japan
    ✓ ISO 9001 industrial scale
    “By harnessing the power of precision fermentation, Spiber engineers proteins at the molecular level, resulting in versatile materials that can be tailored to specific needs.”
    Angel Yeast 安琪酵母 (SSE 600298) China
    ✓ ISO 9001 228,000 tons
    “[Angel Yeast’s 8,500-Ton Specialty Yeast Facility Comes Online, Powering a New Engine for Global Biomanufacturing - Company - Angelyeast”
    Advanced Enzyme Technologies (NSE) India
    ✓ ISO 9001 500 m3
    “Technology: microbial fermentation with ~500 m3 fermentation capacity; 15+ patents; developed/upscaled probiotic production technologies.”
    Absolute India
    industrial scale
    “Uses precision fermentation and proprietary gene-editing tools to deliver diabetes-friendly nutrition for 600 million+ people.”
  2. 2
    ExtractionExtraction
    The biomass is solvent-extracted (or the cell culture harvested) to recover the crude active fraction; the output is a crude extract.
    Who can do this step matched automatically
    Angel Yeast 安琪酵母 (SSE 600298) China
    ✓ ISO 9001 228,000 tons
    “It produces bread/Chinese-staple yeasts, yeast extracts, brewing yeasts, yeast protein and other food ingredients, animal feed additives, and nutrition/health products, leveraging …”
  3. 3
    PurificationPurification & downstream
    The crude extract is purified toward the phytochemical active of interest; the output is a purified active.
    Who can do this step matched automatically
    Advanced Enzyme Technologies (NSE) India
    ✓ ISO 9001 500 m3
    “Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”
    Jiangsu Jland Biotech China
    industrial scale
    “Freeze-dried Eye Patch”
    Space F South Korea
    “2026-07-12 [Korea's next drug lab is in orbit - The Korea Herald — Space LiinTech is advancing Korea’s foray into space-based drug research with autonomous microgravity platforms …”
    Algal Bio Japan
    industrial scale
    “・Equipped with comprehensive downstream processing capabilities (Concentration, sterilization, and drying)”
  4. 4
    Standardization
    The active is marker-standardized to a reproducible clinical-grade phytochemical API or ingredient; the output is a standardized active.
  5. 5
    Clinical evidence
    The standardized active is substantiated with clinical/analytical evidence (e.g. Pharmactive ABG10+ fingerprinting); the output is an evidence dossier.
  6. 6
    FormulationFormulation & blending
    The active is formulated into drug or supplement dosage forms under FDA / EU pharma / NMPA frameworks; the output is a marketable forest-phytochemical product.
    Who can do this step matched automatically
    Advanced Enzyme Technologies (NSE) India
    ✓ ISO 9001 500 m3
    “This is a satellite blending, mixing and formulation facility, located at Vashind near Shahapur and dedicated to the company’s Animal Nutrition business.”

4 · Who delivers

Matched suppliers (matched automatically)

CMPC (BCS: CMPC)ChileProduceractive
re.greenBrazilProduceractive

In the services and supply catalogue 1 · paid service

Contract manufacturing (CMO/CDMO/toll)

Leading companies and institutes (from the brief)

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
Phyton Biotech🇩🇪 Germanypaclitaxel (plant cell fermentation)Taxus cell-culture taxane APICommercial
Indena🇮🇹 Italybotanical extracts / taxanesTaxus baccata paclitaxel recovery, founded 1921Commercial
Sabinsa🇺🇸 USACurcumin C3 Reduct®curcuminoid Novel Food GB authorizationCommercial
Natural Remedies🇮🇳 Indiaherbal / veterinary botanicalsSiddha, Animal Healthcare Innovation CenterCommercial
Pharmactive🇪🇸 SpainABG10+ black garlic, affron saffronclinically-studied phytochemical extractsCommercial

5 · Rules & route to market

Route into Russia / EAEU: PEST · Ministry of Agriculture (Minselkhoz)
2-3 years (registration trials over seasons)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States

The United States contributes curcumin and botanical-ingredient standardization plus the FDA botanical-drug pathway.

Sabinsa, FDA botanical drug guidance#

  • Sabinsa: developed Curcumin C3 Reduct® curcuminoids and secured Great-Britain Novel Food authorization, advancing standardized turmeric phytochemicals for the nutrition market.
  • FDA botanical guidance: the FDA botanical drug development pathway frames US approval of plant-derived therapeutics.
  • Standardization base: US botanical-ingredient firms anchor marker-based standardization for supplement and drug use.
European Union

Europe is the global anchor for botanical-extract API and taxane bioproduction.

Phyton Biotech, Indena, Pharmactive#

  • Phyton Biotech (Germany): produces paclitaxel by plant cell fermentation, advancing sustainable taxane bioproduction that decouples the API from yew-tree harvest.
  • Indena (Italy, founded 1921): a long-standing botanical-extract leader with a taxane-derivative process improving paclitaxel recovery from Taxus baccata.
  • Pharmactive (Spain): supplies clinically-studied ABG10+® aged-black-garlic and affron® saffron phytochemical extracts for the supplement market.
  • EU pharma & Novel Food: EU pharmaceutical legislation and the Novel Food framework frame European plant-derived drugs and botanical ingredients.
China

China’s traditional-medicine heritage anchors a large plant-derived pharma base, though corporate-specific 2026 facts were not pursued in this batch.

Traditional Chinese Medicine phytochemical base#

  • TCM phytochemical base: China’s traditional-medicine industry supplies a large volume of plant-derived phytochemical actives (artemisinin, paclitaxel precursors, ginsenosides) under NMPA oversight and WHO traditional-medicine frameworks.
  • Caveat: this batch did not draft a specific Chinese firm candidate; the CN block is qualitative.
  • Regulatory frame: NMPA governs plant-derived drugs and traditional-medicine products in China.

6 · Money: tenders & grants

GrantStrengthening forest research for the support of Ukraine
European Commission · EU
Sep 22, 2027
341 days

7 · Tech stack & innovations

The stack pairs plant sourcing and extraction with phytochemical standardization and clinical-grade evidence.

  1. Taxane biosynthesis (Taxane Biosynthesis):
    • Phyton Biotech grows Taxus plant cells in fermenters to produce paclitaxel without harvesting yew trees; Indena improves Taxus baccata paclitaxel recovery via its taxane-derivative process.
  2. Botanical solvent extraction (Botanical Solvent Extraction):
    • Indena and Pharmactive extract standardized botanical actives (taxanes, aged-black-garlic allicin, saffron crocins) for pharma and supplement use.
  3. Phytochemical standardization (Phytochemical Standardization):
    • Sabinsa and Pharmactive standardize marker compounds (curcuminoids, ABG10+ markers) to reproducible clinical-grade actives, supported by Novel Food and clinical substantiation.

Sources 5 · 0 independent · 5 producer sites

Producers' own sites 5

  1. Phyton biotech producer checked 2026-06-04 · link not kept
  2. Indena producer checked 2026-06-10 · link not kept
  3. Sabinsa producer checked 2026-06-09 · link not kept
  4. Natural remedies producer checked 2026-06-04 · link not kept
  5. Pharmactive producer checked 2026-06-30 · link not kept